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INTRODUCTION 
Stroke is one of the most important non- communicable disease of public health 
importance. Stroke is defined as an abrupt onset of a focal neurological deficit that is 
attributable to a focal vascular cause. WHO (World Health Organization) defines the 
syndrome of stroke as ―rapidly developing clinical signs of focal or global disturbance of 
cerebral function with symptoms lasting or leading to death, with no apparent cause other 
than vascular origin‖. 
It includes  
1. Sub arachnoid hemorrhage  
It excludes  
1. Transient ischemic attack 
2. Subdural hematoma  
3. Subdural hemorrhage  
4. Infarction caused by infection or tumor 
History of stroke dates to 400 B.C, when Hippocrates first described the medical 
aspects of stroke. Anatomy of brain was first brought to spotlight by Andreas Vesalius in 
the 16
th
 century. Attention on pathology, cause of disease, disease presentation evolved 
over 17
th
 and 18
th
 century. 
The major outbreak in the investigation of stroke cases came in the mid 1960‘s 
with the introduction of computed tomography by Hounsfield. It allowed clear  
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distinction between brain ischemia and hemorrhage and allowed description of size and 
location of the lesion. Further advance came in the form of MRI brain which helped 
anatomical and physiological correlation. 
Medical treatment changed dramatically during later portions of the twentieth 
century after some of the risk factors has been well enumerated. Usage of aspirin after 
widespread therapeutic trials having been proven beneficial was in vogue since 1970‘s. 
Treatment of acute stroke patients was again refined after the approval of thrombolytic 
therapy in late 90‘s. Stroke which was once thought to be irremediable disease now has 
gone to the extent of viewing it as an emergency ―Time lost is brain lost.‖ 
Stroke represents the third leading cause of death after Coronary artery disease 
and Cancer in the west with overall prevalence of 800 per lakh population. There is a lack 
of reliable information on epidemiology of stroke in our country. But community surveys 
from different regions of India showed a Crude Prevalence Rate of stroke presumed to be 
of vascular origin in the range of 203 per lakh population.  
Stroke is a result of series of insult to cerebral and cardiovascular systems. The 
insult comes in the form of risk factors which appreciably differs for different 
communities. Stroke prevention strategies now revolve around the management of these 
risk factors which forms the backbone of the management of stroke in current era. 
Socioeconomic factors, dietary habits, lifestyle behaviors, different patterns of risk 
factors and environmental conditions have shown varying incidence of stroke observed in 
different parts of the world. Present statistics are in major part contributed by the studies 
from the developed countries. Since various ethnic groups and communities exists in our 
country, we need more studies from our nation involving large population to find out the  
 
3 
corresponding incidence, prevalence, morbidity, mortality, risk factors and outcome. This 
will enable us to devise our own strategy in the primary prevention of stroke for our 
population. 
Stroke is a leading cause of disability in adults of stroke survivors. Of the 100 
stroke survivors 30 % requires assistance with activities of daily living, 20 % requires 
assistance for ambulation and 16 % requires institutional care. Hence both directly and 
indirectly there is an appreciable loss of national economy. 
As the projected mortality and morbidity by WHO shows an increasing trend 
more attention should be made to find out the high risk population and focus on 
prevention strategies. 
As with the ethnic and racial variations found in a number of studies, by initiating 
this study an attempt is made to compare the  
1) age predilection  
2) clinical presentation 
3) type of lesion  
4) risk factor profile  
5) outcome  
in male and female population selected from urban Tamilnadu. 
This study would throw light on the differences in the clinical profile of stroke 
between the representative samples of male and female population and thereby to 
formulate newer stroke prevention strategies.  
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REVIEW OF LITERATURE 
WHO defines stroke as a syndrome of ―rapidly developing clinical signs of focal 
or global disturbance of cerebral function with symptoms lasting or leading to death, with 
no apparent cause other than vascular origin‖38. 
The initial definition of transient ischemic attack (TIA) required that all 
neurologic signs and symptoms resolve within 24 hours regardless of whether there is 
imaging evidence of new permanent brain injury and stroke is said to have occurred if the 
neurologic signs and symptoms last for more than 24 h. However, a newly proposed 
definition classifies those with new brain infarction as ischemic strokes regardless of 
whether symptoms persist.
6, 26
 
Definition of stroke is clinical, and laboratory studies including brain imaging are 
used to support the diagnosis. 
EPIDEMIOLOGY: 
MORBIDITY3:  
According to WHO neurological disorders constitute 6.3 % of the global burden 
of disease, out of which 55% (3.46% of total global burden of disease) is caused by 
Cerebro vascular accident. Neurological disorders contribute to 92 million DALY‘s 
(Disability adjusted life year) in year 2005 which has been projected to increase to nearly 
103 million by the year 2030 .Of these cerebro vascular accident contribute to more than  
55 % of the burden in DALY‘s. In future this may have an enormous impact in the health 
care providing system of the country. 
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DALY for individual neurological disorder as % of neurological disorder
41
 
Cerebrovascular disease 55% 
Alzheimer and other dementias 11.9% 
Migraine 8.3% 
Epilepsy 7.9% 
Tetanus 7% 
Meningitis 5.8% 
Parkinson‘s disease 1.8% 
Multiple sclerosis 1.6% 
Japanese encephalitis 0.6% 
Poliomyelitis 0.1% 
 
 
Number of DALYs for cerebro vascular accident and as percentage of global                                                            
DALYs projected for 2005, 2015 and 2030
41
 
 
YEAR 
 
No. of DALY‘s lost (in 
1000‘s) 
 
% of total DALY 
2005 50,785 3.46 % 
2015 53,815 3.63 % 
2030 60,864 3.99 % 
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In the south East Asian countries DALY lost due to cerebro vascular accident has 
been 1.93 %
41
. The burden has been on the high in developing countries reflecting a 
double burden due to coexistence of communicable and non – communicable diseases. 
Stroke is among the top five important causes of disability in both developing and 
developed countries. Increase in life expectancy can ultimately increase the burden in 
health care in forthcoming years in countries like ours. Number of DALY lost for our 
Indian scenario was about 5.8 millions in the year 1998 and has increased to the extent of 
6.4 millions in the year 2004. 
MORTALITY41: 
Cerebro vascular accident is the second worldwide leading cause of mortality as 
per WHO statistics
6
. Neurological diseases constitute 12 % of total mortality worldwide, 
out of which cerebro vascular accident is responsible for 85 % (9.9 % of total mortality). 
The mortality rate for Cerebro vascular accident in developing countries accounts 
to around 15 %.The mortality rate due to Cerebro vascular accident in India is 0.6/1000 
population.(1.2 % of total deaths in India) 
Deaths attributable to Cerebro vascular accident as percentage of total deaths  
2005, 2015 and 2030
41
 
YEAR MORTALITY RATE  
2005 9.9 % 
2015 10.19 % 
2030 10.63 % 
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Mortality for individual neurological disorder as % of total neurological disorder
41
 
Cerebrovascular disease 85% 
Alzheimer and other dementias 6.28% 
Tetanus 2.83% 
Meningitis 2.24% 
Epilepsy  1.86% 
Parkinson's disease  1.55% 
Multiple sclerosis 0.24% 
 
INCIDENCE AND PREVALENCE: 
According to WHO the age-standardized incidence rates per 100,000 varied from 
101 to 285 in men and from 47 to 198 in women
71
. Wide range of variability is due to the 
ethnic and racial variation influencing the stroke epidemiology. The age-standardized 
prevalence rates per 100,000 were between 250 – 35018. 
There is a significant variation among different communities and regional groups 
eg. there is a higher incidence of stroke among African Americans in U.S , as also the 
presence of stroke belt in southeastern U.S. In India, the prevalence of stroke has been 
estimated at 203 per 100,000 population older than 20 (Anand and others 2001)
42
. Stroke 
incidence is heterogenous in population and changes over time. In our country many 
studies are needed to be conducted in various regions to identify the stroke patterns.  
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The prevalence rates of stroke from various major epidemiological studies in India
18
 
Zone Place Rural/ 
Urban 
Year Population Crude 
Prevalence 
Rate per 
100000 
Age adjusted 
prevalence 
Rate per 
100000 
North Haryana Urban 1971-1974 79,046 44  
Kashmir Rural 1986 63,645 143 244 
West Mumbai Urban 1985 14,010 842 424 
Mumbai Urban 1997 145,456 220  
East West Bengal Rural 1989-1990 37,286 126  
West Bengal Rural 1992-1993 20,842 147  
Kolkata Urban 1989-1999 50,291 147 334 
South Vellore Rural 1969-1971 258,576 57 84 
Karnataka Rural 1982-1984 
 
57,660 52  
Bangalore Rural 1993-1995 51,055 165 262 
Bangalore Urban 1993-1995 51,502 136  
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The Annual incidence rates of stroke from various epidemiological studies in India
18
 
Place Rural/ 
Urban 
Year Population Crude 
Incidence 
Rate per 
100000 
Age adjusted 
incidence 
Rate per 
100000 
Vellore Rural 1969-1971 258,576 13  
Kolkata Urban 1998-1999 50291 36 105 
West 
Bengal 
Rural 1993-1998 20842 124 262 
 
CLASSIFICATION: 
ISCHEMIC STROKE: 
 Acute occlusion of intracranial vessel causing reduction in blood flow to the brain 
region it supplies. It accounts to 80 % of all strokes. 
 MAIN CAUSES1, 4, 14 include 
1. ATHEROTHROMBOSIS  
MOST COMMON SITE OF OCCURANCE
14, 4
:  Major arterial branches (e.g., 
the carotid bifurcation in the neck or intracranial branch points) and at vessel 
origins (e.g., the origin of the vertebral artery from the subclavian artery). 
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2. EMBOLIC OCCLUSION 
POTENTIAL SOURCES OF CARDIOEMBOLISM
4
: Atrial fibrillation, Mural 
thrombus, Ventricular akinesis after myocardial infarction, Dilated 
cardiomyopathy, and Valvular disease. 
3. HYPERCOAGULABLE STATES 
MOST COMMON CAUSES
1
: Antiphospholipid antibody syndrome, Protein C 
& S deficiency, Hyperhomocysteinemia and other coagulopathies.  
4. VENOUS SINUS THROMBOSIS 
MOST COMMON CAUSES
44
: Infection is the most common cause in children 
but in adults, pregnancy, severe dehydration, sickle cell anemia, malignancy, 
and hypercoagulable states contribute majority of cases. 
5. VASCULITIS 
MOST COMMON CAUSES
1
: 
a) Meningovascular syphilis, Arteritis secondary to pyogenic and tuberculous 
meningitis.  
b) Connective tissue diseases like polyarteritis nodosa, lupus erythematosus, 
etc., 
HEMORRHAGIC STROKE: 
It accounts for 20 % of all strokes and is associated with a mortality rate of around 
50 %.  It is of two types 
1. Intracerebral hemorrhage accounting for 15 % 
2. Subarachnoid hemorrhage accounting for 5 % 
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MOST COMMON CAUSES include  
1. HYPERTENSION  
MOST COMMON SITES
4, 14
: Lateral ganglionic
 
and capsular, Thalamus, Lobar 
white matter, Caudate, Pons and Cerebellum. 
2.  NON HYPERTENSIVE CAUSES 
a. Vascular malformations (saccular or mycotic aneurysms, arteriovenous 
malformations,    cavernous angiomas) 
MOST COMMON SITES OF ANEURYSM
14
: Junctions of larger vessels of the 
circle of Willis commonly at internal carotid artery with posterior communicating 
artery junction, anterior cerebral artery with anterior communicating artery 
junction and middle cerebral artery trifurcation. 
b. Intracranial tumors 
c. Bleeding disorders 
d. Anticoagulant and fibrinolytic treatment 
e. Cerebral amyloid angiopathy 
f. Hemorrhagic infarction 
g. Trauma 
 
PATHOPHYSIOLOGY
26, 44:
 
Cerebral blood flow distributes blood to target organ by regulating blood flow and 
distributing oxygen and glucose to the brain while removing the byproducts of 
metabolism. 
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Reduced blood flow to brain causes cerebral ischemia and energy failure is rapid 
as neurons lack glycogen. Ischemia causes impairment of brain energy metabolism, loss 
of aerobic glycolysis, intracellular accumulation of sodium and calcium ions, release of 
excitotoxic neurotransmitters, elevation of lactate levels with local acidosis, free radical 
production, cell swelling, over activation of lipases and proteases, and cell death. 
Normal cerebral blood flow at rest in the normal adult brain is approximately 50-
55 ml /100 g per minute and the cerebral metabolic rate of oxygen is 165 mmol /100 g 
per minute. 
When blood flow decreases to 18 ml /100 g per minute, the brain reaches a 
threshold for electrical failure at which state if blood flow recovers brain tissue also 
recovers.  
When blood flow falls to less than 8 ml /100 g per minute, the neurons reaches the 
threshold of membrane failure and cell death result and thereby causing permanent 
neurological sequelae. 
The ischemic penumbra, or area of misery perfusion, is the area of the ischemic 
brain between these two flow thresholds were some neurons are functionally silent but 
structurally intact and potentially salvageable. 
Hemorrhage is caused by bleeding into or around the brain. It produces 
neurological symptoms by producing a mass effect on neural structures or by the direct 
toxic effect of blood itself or by increasing intracranial pressure.   
 
 
 
13 
 
CLINICAL CLASSIFICATION OF STROKE: 
Oxfordshire / Bamford classification of stroke  8 
The Classification is based on clinical features of the presenting stroke. It allows 
us to reliably comment on stroke territory, allows easy identification of syndromes that 
do not fit classically, and also gives clinical prognostication. However they can be further 
refined by the investigatory modalities like CT or MRI brain. 
 
Total Anterior Circulation Syndrome (TACS) 
 Constitutes 20% of strokes. 
 Diagnosis suspected by the presence of combination of three of the following 
manifestations 
o Motor weakness (with or without sensory deficit in the form of 
hemisensory loss) of at least 2 of 3 body areas (face/arm/leg). 
o Homonymous hemianopia.  
o Higher cerebral dysfunction (dysphasia in dominant hemisphere 
involvement: dyspraxia in non dominant hemisphere involvement). 
 If drowsy with unilateral weakness, other two factors can be assumed to be 
present. 
 
Partial Anterior Circulation Syndrome (PACS) 
 Constitutes 35% of strokes. 
14 
 Diagnosis suspected with the presence of 
o Two of the three of the TACS criteria or 
o Restricted motor/sensory deficit eg. One limb, face and hand 
 Usually not associated with drowsiness   
 Recurrence is high, especially in the first three months. 
 
Lacunar Syndrome (LACS) 
 Constitutes 20% of strokes. 
 Presentation may include the occurrence of any one of the following 
o Pure motor (commonest)- Complete or incomplete weakness of 1 side 
o Pure sensory -Sensory symptoms and/or signs 
o Combination of motor and sensory 
o Dysarthria or dysphasia  
o Ataxic hemiparesis - Hemiparesis and ipsilateral cerebellar ataxia.  
 Often CT- MRI will delineate the infarct. It is an intrinsic disease of single basal 
perforating artery (usually end arteries). 
 Often silent and under diagnosed. 
 
Posterior Circulation Syndrome (POCS) 
 Constitutes 25% of strokes. 
 Affecting brainstem, cerebellar or occipital lobes.  
  Thrombosis is more pronounced than embolism.                                                   
 Presentation is variable and frequently complex. It includes  
15 
o Bilateral motor/sensory deficit 
o Disordered conjugate eye movement 
o Isolated homonymous hemianopia 
o Ipsilateral cranial nerve palsy with contra lateral motor and or sensory 
deficit 
o Coma, disordered breathing, and horner‘s syndrome  can be associated. 
 
 
 
 
 
 
 
 
 
 
 
 
16 
BAMFORD CLASSIFICATION OF STROKES
 8
 
 
Syndromes 
 
TACS PACS LACS POCS 
Site Of 
Lesion 
Fronto -tempo- 
Parietal lobes 
Thalamus/internal 
capsule/occipital 
Lobar Small deep 
lesion in corona 
radiata, internal 
capsule, 
thalamus or 
ventral pons 
Brain stem/ 
cerebellum/occipital 
lobe 
Pathology  
85% 
 
85% 
 
95-98% 
 
85% 
Infarction 
 
Hemorrhage 15% 15% 2-5% 15% 
Etiology  
Occlusion of 
Ipsilateral ICA or 
MCA and 
occasionally 
PCA; by 
embolism from 
heart, aortic arch 
or carotid or 
vertebrobasillar 
arteries, or in situ 
thrombosis. 
 
Occlusion 
of branch 
of MCA 
or  PCA; 
by 
embolism 
from 
heart, 
aortic 
arch.  
 
Usually 
lipohyalinosis, 
microatheroma 
or ‗complex 
disease‘ 
(fibrinoid 
necrosis) of 
small 
perforating 
artery. Rarely 
arteritis or 
embolism. 
 
Occlusion of VBA 
or PCA , or 
branches ; by insitu 
thrombosis or 
embolism from 
heart, aortic arch or 
VBA.  
 
 
 
 
 
 
 
 
Hemorrhage Any of possible  
cause 
Any of 
possible 
cause 
Any of possible 
cause 
Any of possible  
cause 
Recurrence 
Rate 
low High in 
first 3 
months 
Low but steady 
over 12 months 
High in first 2 
months and steady 
over 12 months 
 
(Adapted from Hankes and Lees, 2001) 
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RISK FACTORS OF STROKE: 
Various epidemiological studies have indicated that stroke does not occur at 
random. It has been found that several factors precede the disease which contributes to 
the occurrence of stroke. These are called RISK FACTORS
46
. 
The consequences of this preventable epidemic will have an impact on individual 
mortality and morbidity, family suffering, and staggering economic costs. The 
intervention in these risk factors can be widely applied because of their low cost and 
minimal risk
46
. Hence evaluation of the clinical risk profile can help us to decide on the 
preventive treatment which is to be offered.  
The significance of a risk factor is determined by the relative risk which 
represents the strength of the association between the risk factor and the chance of having 
a stroke. Population attributable risk is of more relevance in considering the importance 
of a risk factor in a particular population. 
Identification of the clinical patterns and the risk factors and to control or modify 
the risk factors remain the most important means of reducing the stroke incidence in 
western nations
58 
which has been brought about by several population based studies. 
Hence more number of studies need to be done in our country to find the risk factor 
profile of our nation. 
The most important means of reducing stroke incidence and there by stroke 
disability is by modifying the risk factors to the extent possible. Hence complete 
knowledge about the risk factors in the prevailing area is absolutely essential. 
Risk factors have been classified into non modifiable and modifiable.  
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NON MODIFIABLE RISK FACTORS51: 
 Age 
 Gender 
 Race/Ethnicity 
 Family history 
 Genetics 
As these factors are non modifiable they don‘t contribute much for the framing of 
prevention strategy measures. Hence more importance has been insisted on the 
prevention strategy based on the modifiable risk factors.  
MODIFIABLE RISK FACTORS51: 
 Arterial hypertension  
 Asymptomatic carotid bruit      
 Cardiac disease 
 Diabetes mellitus 
 Dyslipidemia 
 Cigarette smoking 
 Alcohol consumption 
 Elevated homocysteine 
 Low serum folate 
 Elevated anticardiolipin antibodies 
 Oral contraceptive use 
 Obesity  
 Prior stroke 
19 
 Aortic arch atheromatosis 
 Increased fibrinogen levels 
These risk factors are of prime importance as they could be used for the framing 
of prevention strategies. 
 
NON MODIFIABLE RISK FACTORS: 
Spotlights people at increased risk of stroke. These are the factors towards which 
the prevention strategies could not be targeted. 
AGE: 
Stroke incidence increases dramatically with increasing age. Increasing age is the 
most powerful risk factor for stroke
64
. The incidence of stroke doubles each decade past 
55 years of age. Half of all strokes occur in people older than 70 to 75 years. Men 
develop ischemic strokes at higher rates than women up to the age of 75 years.  
The mean age of stroke presentation is 57 to 71 yrs is relatively lesser in Asian 
population than in than west of 76 to 80 yrs
58, 34, 32
. Atherosclerosis and cardio embolism 
secondary to atrial fibrillation are the leading cause of ischemic stroke in elderly while 
cerebral amyloid angiopathy and chronic hypertension are the leading causes of 
intracerebral hemorrhage in elderly
54
. 
FAMILY HISTORY: 
An increased risk is seen with a family history of stroke among first-degree 
relatives. There are a number of genetic causes of stroke. Some inherited diseases like 
hereditary dyslipoproteinemias which predispose to accelerated atherosclerosis,  
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coagulopathies, and tendencies for intracranial aneurysms and AV malformations 
increases the chance of getting a stroke. 
Also presence of the apolipoprotein K2 allele in elderly individuals and the 
deletion of the gene for the angiotensin converting enzyme may increase the risk of 
stroke. But it is somewhat controversial. 
Other Potential
 
reasons for stroke to run in families are genetic determination
 
of 
stroke risk factors, and a common familial exposure
 
to environmental or lifestyle risks. 
Earlier studies suggested an
 
increased risk for men whose mothers died of stroke and 
women
 
who had a family history of stroke. In the Framingham Study offspring analyses 
revealed that both paternal and maternal histories
45
 were associated with an increased risk 
of stroke
78
. 
GENDER: 
Men develop ischemic strokes at higher rates than women up to the age of 75 
years. The male-to-female ratio was one to seven71.  Stroke incidence rates are 1.25 times 
greater in men, but because women tend to live
 
longer than men, more women than men 
die of stroke each year. Mean age of females is more than that of males
58
.  
Stroke is uncommon among women of childbearing age. The relative risk of 
stroke is increased among users of high-dose estrogen oral contraceptives, particularly 
with coexistent arterial hypertension, cigarette smoking, increasing age, migraine, and 
saccular aneurysm
3
. 
Risk of thrombosis associated with pregnancy is high in the postpartum period. 
The risk of cerebral infarction is increased in the 6 weeks after delivery but not during 
pregnancy. 
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Compared with males, female
 
patients were significantly showed higher
 
level of 
handicap, as defined by prestroke Rankin Scale, and
 
a higher frequency of hypertension, 
atrial fibrillation, and
 
antihypertensive treatment. History of myocardial infarction,
  
current or previous smoking, alcohol consumption, and antiplatelet
 
therapy were 
significantly more frequent in male patients
5
  
Two recent postmenopausal hormone replacement studies showed no benefit in 
reducing the incidence of stroke in a cohort of women with coronary heart disease 
(Hulley et al. 1998; Herrington et al. 2000)
28
. 
Women's Health Initiative, a prospective randomized trial of estrogen therapy in 
healthy postmenopausal women, was halted prematurely because the risks outweighed 
the benefits. Absolute excess risks per 10,000 person-years attributable to estrogen plus 
progestin were Eightfold for strokes
55
 (Writing Group for the Women's Health Initiative 
Investigators. 2002) 
RACE/ ETHNICITY: 
Clinical profile and outcome has been studied in various populations and have 
shown significant variations among different races. 
The rate of cerebral infarction is higher in blacks than in whites; this could be 
partially explained by the higher prevalence of diabetes and arterial hypertension 
experienced by blacks. Blacks also have higher rates of intracranial atherosclerotic 
occlusive disease, compared with whites
58
. 
Also most of the local southasian and far eastern studies have suggested that the 
proportion of intracerebral hemorrhage was significantly higher 20 – 45 % than in the 
west 10 – 20 % : while cerebral infarction varied between 55 – 70 % in the local studies 
and 60- 85 % in the western studies.
9, 58, 59
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The stroke incidence and case fatality rates are also markedly different among the 
major ethnic groups in Auckland and New Zealand. Maori and Pacific Islands people 
have a higher mortality within 28 days of stroke when compared with Europeans, 
especially men
10
. 
 
MODIFIABLE RISK FACTORS: 
Risk factor which can be controlled or modified thereby decreasing the incidence 
of stroke is the prime focus of management in this era. From a practical viewpoint, these 
risk factors that have emerged from various studies are modifiable by lifestyle and/or 
pharmacotherapy. 
The major risk factors are discussed. 
HYPERTENSION: 
Hypertension is the most important modifiable determinant of both first and 
recurrent stroke (Eastern Stroke and Coronary Heart Disease Collaborative Research 
Group 1998)
42
. Arterial hypertension predisposes to ischemic stroke by aggravating 
atherosclerosis and accelerating heart disease, increasing the relative risk of stroke three 
to fourfold.  
Treatment of systolic hypertension slows the progression of atherosclerosis. 
Decreasing   systolic blood pressure by approximately 10 mmHg reduces the relative risk 
of stroke by 35% to 40%.The PROGRESS Trial evaluated the effects of antihypertensive 
on the risk of stroke in patients with histories of stroke or transient ischemic attack  
(TIA). Regardless of blood pressure at entry, patients clearly benefited from treatment 
(PROGRESS Collaborative Group 2001)
52
. 
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Lowering blood pressure to levels below those traditionally defining hypertension 
appears to reduce the risk of stroke even further. The risk is greater for patients with 
isolated systolic hypertension and elevated pulse pressure and hence treatment of isolated 
systolic hypertension in the elderly has proven to be effective in reducing stroke risk. 
Blood pressure treatment, resulting in a reduction in systolic of 10-12 mm Hg and 
5-6 mm Hg diastolic, is associated with a 38% reduction in stroke incidence. Lowering 
blood pressure in stroke survivors helps prevent recurrent stroke and is more important 
than the specific hypotensive agent used.   
Data are particularly strong in support of thiazide diuretics, angiotensin-
converting enzyme inhibitors, and angiotensin receptor blockers. However, the effects of 
blood pressure lowering agents may vary in the different age groups
53 
Hypertension is the most readily recognized factor in the genesis of primary 
intracerebral hemorrhage. 
The cooperative studies of the Veterans Administration (Freis et al) and the report 
by Collins and associates (collating 14 randomized trials of antihypertensive drugs) have 
convincingly demonstrated that the long-term control of hypertension decreases the 
incidence of both atherothrombotic infarction and intracerebral hemorrhage. 
DIABETES MELLITUS: 
Diabetes mellitus hastens the atherosclerotic process in both large and small 
arteries. Weinberger and colleagues and Roehmholdt and coworkers have found diabetic 
patients to be twice as liable to stroke as age matched nondiabetic groups
76
. The diabetes 
is an independent risk factor among the associated risk factors as found in a number of 
large prospective studies, including Gothenburg cohort study, and the Framingham study. 
24 
The relative risk of stroke in diabetes is higher in women, and may be as high as 
13 times the normal risk in the younger age groups. High insulin levels increase the risk 
for atherosclerosis and may represent a pathogenetic factor in cerebral small vessel  
disease. 
There is a fourfold increase in the relative risk of cardiovascular event among 
patients with diabetes and hypertension than among those without the two conditions
 
(HT 
and DM study…HDS 1993)29. There in more than an additive risk when both conditions 
co exist.  
The frequency of diabetes mellitus is found to be higher in Indian population  
18% -42.5% when compared to the western population 10%-26%, adding to the risk of 
disease burden
73
. The resulting impairment tends to be greater and survival poorer in 
diabetics than in nondiabetic stroke patients. 
Diabetic persons with retinopathy and autonomic neuropathy appear to be a group 
at particularly high risk for ischemic stroke. However, presently no evidence exists that 
tighter diabetic control over time decrease the risk of stroke or stroke recurrence. 
DYSLIPIDEMIA:  
High Total Cholesterol and High Low-Density Lipoprotein concentration have 
well correlated with atherosclerosis of cerebral vasculature. Low total cholesterol has 
been associated with hemorrhagic stroke
81, 62
. Carotid atheroma is linked to increased 
LDL and may be inversely related to HDL .But HDL association is less clear in relation 
to CVA.  Lipid-lowering agents may slow progression of atherosclerotic plaque growth 
and may possibly cause a regression in plaque formation
12
. 
In Scandinavian Simvastatin Survival Study, the post hoc analysis have showed a 
28% reduction in fatal or nonfatal stroke and TIAs
60,39,47
(Pedersen et al. 1998). 
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The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID)
50
 reported 
20% reduction in the risk of stroke.  
Several trials have confirmed that statin drugs reduce the risk of stroke even in 
patients without elevated LDL or low HDL. The recently reported SPARCL (Stroke 
Prevention by Aggressive Reduction in Cholesterol Levels) trial showed benefit in 
secondary stroke reduction for patients with recent stroke or TIA who were prescribed 
atorvastatin, 80 mg/d. Although studies specifically targeting primary prevention of 
stroke are still underway, results for patients with cardiovascular risk factors or 
dyslipidemia have been compelling, with a 16–30%relative risk reduction for stroke. 
CIGARETTE SMOKING AND TOBACCO CHEWING:  
Cigarette smoking is a major risk factor for stroke
78, 70
. It is a very important 
preventable cause of stroke.  Cigarette smoking is an independent risk factor
25 
for 
ischemic stroke in men and women of all ages, and a leading risk factor of carotid 
atherosclerosis in men
30
. 
The risk of stroke in smokers is two to three times greater than in nonsmokers. 
Heavy smoking (more than one pack per day) carries eleven times the ischemic stroke 
risk and four times the subarachnoid hemorrhage risk of people who do not smoke.  The 
mechanisms of enhanced atherogenesis promoted by cigarette smoking are incompletely 
understood, but include reduced capacity of the blood to deliver oxygen, cardiac 
arrhythmias, and triggering of arterial thrombosis and arterial spasm. Some of the studies 
have shown betel nut chewing with or without tobacco is associated with increased risk 
of stroke
7
.  
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Smoking with oral contraceptives carries 22 times the risk of stroke without them 
in females. More than 5 years may be required before a reduction in stroke risk is 
observed after cessation of smoking
51, 75
. 
 ALCOHOL CONSUMPTION: 
A J-shaped association between alcohol consumption and ischemic stroke exist. 
Light to moderate use (up to two drinks a day) evenly distributed throughout the week 
offers a reduced risk and may elevate HDL concentration
58, 57, 72
, whereas heavy drinking 
is associated with an increased risk of total stroke. . Heavy drinking has a different cut off 
for a male and a female. Heavy drinking is considered when a male take more than 35 – 
45 gm per day and that when a females take more than 22 – 30 gm per day. This 
association is found predominantly in white population. In a study conducted in a cohort 
in population of Sweden it has been demonstrated that ischemic stroke was found in men 
(not females) who were intoxicated or had reported episode of binge drinking a few times 
a year  
Alcohol may induce arrhythmias and cause Cardiomyopathy with global 
hypokinesis, thereby predisposing to formation of cardiac emboli. Alcohol has also been 
linked to hypertension, increased platelet aggregation, and decreased production of 
circulating clotting factors due to insult to liver and hence contributing to stroke.   
The association between alcohol consumption and stroke risk appears much 
stronger for intracerebral and subarachnoid hemorrhage than for ischemic stroke
72
. In 
western studies it has shown the risk of hemorrhagic stroke more than doubled for light 
drinkers and nearly tripled for those considered to be heavy drinkers. Positive linear 
relationship has been demonstrated between moderate alcohol consumption and risk of 
intracerebral hemorrhage. A reduction in alcohol consumption was accompanied by a  
27 
reduction in subsequent hemorrhagic stroke suggesting a possible causal relation between 
the two.  
VENOUS THROMBOSIS: 
Cerebral vein thrombosis (CVT) is a rare but important cause of stroke that is 
often missed or discovered late in diagnosis
12
. Infection is the most common cause of 
CVT in children whereas in adults, most are associated with postpartum
42
. Infrequent 
etiologies include severe dehydration, sickle cell anemia, malignancy, hypercoagulable 
states and usage of oral contraceptive agents. 
Severe headache, nausea, and vomiting are nonspecific but common symptoms. 
Papilledema may be the only abnormality on initial examination. Fluctuating focal 
neurologic deficits, such as unilateral weakness, numbness, or seizures, may appear.  
Noncontrast CT will determine whether acute hemorrhage or mass effect is 
present but Contrast CT may demonstrate the empty delta sign in the sagittal sinus. MRI 
and MR venogram have better sensitivity for detection of CVT. Gold standard diagnostic 
tool is conventional cerebral angiography. A small randomized trial demonstrated safety 
and efficacy of intravenous heparin in CVT, even in patients with preexisting 
hemorrhage. Consequently, acute anticoagulation is recommended for most patients with 
CVT. After the acute period, oral anticoagulation is typically used for several months 
until MRI or MRV demonstrates sinus patency. 
Mortality from CVT is estimated to be 5% to 30%, but survivors have a good 
prognosis with little residual deficit
44
. 
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PHYSICAL ACTIVITY:
 
Regular exercise lowers blood pressure, decreases insulin resistance, increases 
HDL Cholesterol, and is associated with lower cardiovascular morbidity and mortality. 
Medium to high levels of physical exercise has shown to decrease the incidence of stroke 
in both men
49 
and women
48
. Habitual snoring increases the risk of stroke. It adversely 
affects outcome of patients admitted to the hospital with stroke. 
OBESITY: 
The prevalence of obesity has increased particularly in the western countries. 
More than 61% of adult Americans are overweight, and 27% are obese.  
Obesity, particularly abdominal or truncal is an important risk factor for 
cardiovascular disease in men and women of all ages.  
ATRIAL FIBRILLATION: 
           Cardio embolism is associated with 20 % of all ischemic strokes
79
. The most 
significant causes of cardio embolic stroke in most of the world are nonrheumatic (often 
called nonvalvular) atrial fibrillation, acute myocardial infarction, prosthetic valves, 
rheumatic heart disease, and ischemic Cardiomyopathy.  Atrial fibrillation is associated 
with an overall risk of stroke of approximately five to six folds, and a mortality of 
approximately twice that of age and sex matched individuals without atrial fibrillation.  
           Nonrheumatic atrial fibrillation is the most common cause of cerebral embolism 
overall. Prevalence of non valvular atrial fibrillation (NVAF) increases with advancing 
age. The number
 
of patients with atrial fibrillation is likely to increase 2.5-fold
 
during the 
next 50 years in the west, reflecting the growing proportion
 
of elderly individuals. 
Coordinated efforts are needed to face
 
the increasing challenge of optimal stroke  
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prevention and rhythm
 
management in patients with atrial fibrillation. (JAMA. 2001; 285: 
2370-2375). 
                Heart failure, arterial hypertension, diabetes, prior stroke or TIA, prior cardio 
embolism, poor left ventricular function, mitral stenosis, prosthetic heart valve, and 
increasing age increase the risk of embolism in patients with atrial fibrillation. High-risk 
patients have a 5-7% yearly risk of thromboembolism. 
CAROTID ARTERY DISEASE: 
Asymptomatic carotid disease carries a greater risk of vascular death from 
coronary artery disease than from stroke. Persons with an asymptomatic carotid bruit 
have an estimated annual risk of stroke of 1.5% at 1 year and 7.5% at 5 years. 
Asymptomatic carotid artery stenosis less than 75% carries a stroke risk of 1.3% 
annually; with stenosis greater than 75%, the combined TIA and stroke rate is 10.5% per 
year, with most events occurring ipsilateral to the stenosed carotid artery
19
. Symptomatic 
carotid artery stenosis greater than 70% carries an annual risk of stroke of approximately 
15%. 
Plaque structure rather than degree of carotid artery stenosis may be a critical 
factor in determining stroke risk. Ultrasonographic carotid artery plaque morphology may 
identify the subgroup of patients at high risk of stroke. 
PRIOR STROKE: 
Patients with a first stroke are at greater risk of recurrent stroke, especially, early 
after the first stroke. Those who suffer a recurrent stroke have a higher mortality than 
patients with first stroke. If the recurrence is contralateral to the first stroke, prognosis for 
functional recovery is poor.  
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ELEVATED FIBRINOGEN LEVELS: 
 Elevation of plasma fibrinogen is an independent risk factor for the development 
of stroke. Also fibrinogen levels are closely correlated with other stroke risk factors such 
as cigarette smoking, arterial hypertension, diabetes, obesity, hematocrit levels, and 
spontaneous echocardiographic contrast. 
HOMOCYSTEINE ELEVATION: 
 Fasting total homocysteine (normal 5-15 mmol/L), a sulfhydryl-containing amino 
acid, have been associated with an increased risk of stroke
58
 and thrombotic events in 
case-controlled studies. It predisposes young individuals to vascular events due to its 
procoagulant state and is an independent risk factor for stroke. Hyperhomocysteinemia 
can be caused by an error in metabolism of sulphur containing amino acids. Other causes 
of homocysteine elevation are nutritional deficiencies of vitamin B6, B12, folic acid and 
genetic defect in the methylene tetrahydro folate reductase gene. Serum folate 
concentrations less than or equal to 9.2 mmol/liter have been associated with elevated 
plasma levels of homocysteine, and a decreased folate concentration alone may be a risk 
factor for ischemic stroke, particularly among blacks (Giles et al. 1995). 
           Despite of clear evidence from Framingham study  and  Rotterdam study that the 
elevated plasma levels of homocysteine are associated with a higher risk of vascular 
events independently, many prospective treatment trials provide no evidence that folic 
acid and vitamin B therapy can reduce the subsequent vascular events in patients with 
elevated homocysteine even though they can decrease the plasma levels of homocysteine 
further more the combination of folic acid and vitamin B therapy  may actually be 
harmful in some patients group.                                                                                                                       
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ANTI PHOSPHOLIPID ANTIBODY SYNDROME: 
 The presence of anticardiolipin antibodies in association with thrombotic events 
without evidence of connective tissue disease is referred to as primary antiphopholipid 
syndrome. Lupus anticoagulant and anticardiolipin antibodies are recognized markers for 
increased risk of thrombosis, abortion, cerebral ischemia and multiinfarct state. 
Various studies showed that among patients with antiphospholipid antibody
23
, 
around 30% had neurological manifestations consistent with cerebral infarct, better 
correlating with IgG than IgM antibody. Patients with higher levels of antibodies are 
likely to have multiple cerebral infarcts than those with lower levels. 
PREVENTION OF STROKE
46
 
The accumulated evidence from various studies lead to broad consensus of expert 
opinion that stroke is preventable. This is best expressed in a report of WHO expert 
committee as following. 
 PRIMARY PREVENTION  
1. Population strategy 
      A. Prevention in whole population 
      B. Primordial prevention in whole population 
           2. High risk strategy 
 SECONDARY PREVENTION 
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PRIMARY PREVENTION51: 
          It is the action taken prior to the onset of disease, which removes the possibility 
that a disease will occur. It can be implemented by means of targeting at the whole 
population irrespective of the individual risk level or by targeting the high risk 
populations
58
. Attempting to provide stroke prevention therapy to general population is 
not cost effective whereas identifying and giving therapy to people with risk factors for 
stroke i.e., high risk population is cost effective and lead to significant reduction in 
morbidity and mortality from stroke.  
           The population strategies centre around good control of hypertension, diabetes, 
and dyslipidemia by pharmacotherapy and behavioral modifications like abstaining from 
smoking and alcoholism. Emphasis should also be made on dietary modifications and 
encouraging physical activities.  
               This prevention strategy involves the use of mass media and public education 
systems
58
. So by targeting high risk population a heavy economic benefit is obtained by 
reducing the DALY which would have been lost otherwise.  
                The primordial prevention is a novel approach to primary prevention of stroke. 
It involves the prevention of emergence and spread of risk factors and life styles that have 
not been observed in population. 
SECONDARY PREVENTION: 
                   The aim of secondary prevention is to prevent the recurrence and progression 
of the stroke. It is a continuation of primary prevention in a post stroke patient. The 
principles governing secondary prevention are the same as those of primary prevention. 
Early diagnosis and management of stroke improves the outcome in the diseased 
individual.  
33 
Complementary strategies
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can be used to lessen the impact of the disease. 
 Risk factors can be lowered through population-wide public health 
measures, such as national campaigns.  
 Identification of higher-risk subgroups of the population who stand to 
benefit the most from specific, low-cost prevention interventions. 
 Resources should be allocated to acute as well as secondary prevention 
interventions. For countries with limited resources, a critical first step in 
developing a comprehensive plan is better assessment of cause-specific 
mortality and morbidity, as well as the prevalence of the major 
preventable risk factors. 
PREVENTING STROKE RECURRENCE BY MEDICAL 
THERAPY 
Evidence from several clinical studies favors the use of platelet antiaggregants as 
the first line of therapy in patients at high risk for stroke (Antithrombotic Trialists' 
Collaboration 2002).  These agents are indicated for secondary prevention of stroke. 
Meta-analyses have shown that aspirin reduces the combined risk of stroke, myocardial 
infarction, and vascular death by approximately 25%
59. The optimal dose of aspirin 
remains a source of controversy. Two large trials, the International Stroke Trial (IST) and 
the Chinese Acute Stroke Trial (CAST), found that the use of aspirin within 48 h of 
stroke onset reduced both stroke recurrence risk and mortality minimally
15
. 
  Ticlopidine reduces the relative risk of death or nonfatal stroke by 12% in 
comparison with aspirin but has the disadvantage of causing diarrhea, skin rash, 
neutropenia and thrombotic thrombocytopenic purpura. The Clopidogrel versus Aspirin  
34 
in Patients at Risk of Ischemic Events study (CAPRIE) assessed the relative efficacy of 
clopidogrel (75 mg daily) and aspirin (325 mg daily) in reducing the incidence of 
ischemic stroke, myocardial infarction, or symptomatic atherosclerotic peripheral arterial 
disease
60
. The results of this study showed that clopidogrel was modestly more effective 
(8.7% relative risk reduction) than aspirin in reducing the combined risk of ischemic 
stroke, myocardial infarction, and vascular death in patients with atherosclerotic disease. 
But aspirin is inexpensive, can be given in low doses, and could be recommended for all 
adults to prevent both stroke and MI. Management of Atherothrombosis with Clopidogrel 
in High-Risk Patients (MATCH) trial compared clopidogrel in combination with aspirin 
to clopidogrel alone in the secondary prevention of TIA or stroke. The MATCH trial 
found no difference in TIA or stroke prevention with this combination, but did show a 
small but significant increase in major bleeding complications (3% vs. 1%)
 17
. 
To date there is no evidence to support the use of aspirin in primary prevention of 
stroke among low-risk, middle-aged people.  
Oral anticoagulation with warfarin is indicated for primary and secondary 
prevention of stroke in patients with NVAF
 20, 37, 42
. Advancing age increases the risk of 
major hemorrhage in patients given warfarin for stroke prevention. NVAF Patients at 
high risk of stroke should be treated with dose adjusted Warfarin
11
 (INR 2.0-3.0).  
Hypertension is the leading cause of primary intracerebral hemorrhage. 
Prevention is aimed at reducing hypertension, excessive alcohol use, and use of illicit 
drugs such as cocaine and amphetamines. 
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INVESTIGATIONS 
CT scan forms the modality of choice for diagnosis of hemorrhage. It localizes 
small hemorrhage, hemorrhagic infarcts and subarachnoid hemorrhage. Infarcts could be 
localized by it only after 24 to 48 hrs. CT angiogram detects carotid disease and 
intravascular occlusions. 
 Diffusion weighed MRI is the earliest to detect acute infarct. It appreciates infarct 
even within few minutes. It detects small lacunar lesions deep in the hemisphere and also 
shows abnormalities in the brainstem. MR angiogram effectively detects stenosis of 
extracranial ICA and large intracranial vessels. MRI with fat saturation will visualize 
extracranial or intracranial arterial dissection. 
 B mode ultrasound with Doppler detects and quantifies stenosis at the origin of 
ICA. Transcranial Doppler assesses MCA, ACA, PCA flows. 
 Digital arteriography shows occlusion of large vessels, aneurysm, vascular 
malformation and arteritis. Reserved for situations where less invasive measures are 
adequate. 
Lumbar puncture with CSF being hemorrhagic implies bleed into intraventricular 
space. Very minimal bleed can be detected by positivity for CSF xanthochromia. 
 In stroke of unknown origin ECG and echocardiogram are mandatory. In 
suspected embolic stroke transesophageal echo should be advised. Tests regarding 
association of risk factors like ECG, blood sugar levels and serum cholesterol levels 
should be done. On grounds of suspicion of hypercoagulable state like 
hyperhomocysteinemia, antiphospholipid antibody syndrome, protein S and C deficiency, 
investigations should be directed towards it.  
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TREATMENT 
Acute Ischemic Stroke treatments designed to reverse or lessen the amount of 
tissue infarction and improve clinical outcome are as follows. 
(1) Medical Support: Aims to make the undamaged cells to be protected (ischemic 
penumbra) by optimizing cerebral perfusion in that area. Collateral blood flow in the 
ischemic brain is blood pressure dependent and hence it should not be reduced 
drastically, exceptions being malignant hyperthermia, association of myocardial 
infarction, and when BP is < 185/110 mm hg and thrombolytic therapy is anticipated. 
Blood glucose levels should be maintained to <110 mg/dl. 5 to 10 % will develop 
cerebral edema which peaks on the 2nd or 3rd day. IV mannitol is the drug of choice and 
steroids have no role. In cerebellar infarcts in view of impending brain stem compression 
surgical decompression is undertaken almost as soon as the edema becomes clinically 
apparent. 
(2) Intravenous thrombolysis (National Institute of Neurological Disorders and 
Stroke rtPA Stroke Study Group 1995)
42
: Effective if treatment is done within 3 hrs of 
onset
2
. rtPA which converts plasminogen to plasmin which by itself is a proteolytic 
enzyme having the capacity of degrading fibrinogen to fibrin is the drug used at the dose 
of 0.9 mg/kg iv to a maximum of 90 mg. Out of this 10 % is administered as bolus and 
the rest as infusion over 60 minutes. Has 6 % risk of intracerebral bleed.  
(3) Endovascular Techniques: Large clot volume usually fails to open up with iv 
rtPA alone. Intra arterial route increases the concentration of the drug at the site of clot 
and minimizes systemic complications to some extent.  
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In patients who failed to recanulate with rtPA or if patient is ineligible or having 
contraindication for thrombolysis, endovascular thrombectomy can be attempted. Patients 
showed improvement if done within 8 hrs of onset of symptoms. 
(4) Antithrombotic Treatment: Use of aspirin within 48 hrs of onset reduced both 
stroke recurrence risk and mortality (Chinese Acute Stroke Trial Collaborative Group 
1997; International Stroke Trial Collaborative Group 1997)
42
. Due to cost effectiveness, 
aspirin is preferred over clopidogrel. Trials do not support the use of anticoagulants for 
patient with thrombotic stroke. The U.S. Trial of Organon 10172 in Acute Stroke 
Treatment (TOAST), an investigational low-molecular-weight heparin, failed to show 
any benefit over aspirin. Use of SC unfractionated heparin versus aspirin was tested in 
international stroke trial (IST). Heparin given SC afforded no additional benefit over 
aspirin and increased bleeding rates. But there is a role for anticoagulants in ischemic 
strokes. 
(5) Surgical measures: Carotid atherosclerosis can be managed by endarterectomy 
and endovascular stenting with or without balloon angioplasty. 
(6) Neuroprotectives: Drugs that block excitatory amino acids (glutamic acid) and 
hypothermia are said to benefit but yet to be proven in humans. 
(7) Stroke Centers and Rehabilitation: It includes physical therapy, occupational 
therapy and speech therapy. Measures targeted against prevention of pneumonia, UTI, 
DVT, and pulmonary embolism. 
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PROGNOSIS AND OUTCOME 
Prognosis of the stroke depends on several factors such as age, etiology, size of 
the lesion and the time that lapse before initiation of treatment. The prognosis for survival 
after cerebral infarction is better than after cerebral or subarachnoid hemorrhage. The 
only proved effective therapy for acute stroke requires initiation within 3 hours after 
stroke onset, and the prognosis therefore depends on the time that elapses before arrival 
at the hospital. 
Initial stroke severity is one of the strongest predictors of outcome, and early 
evidence of improvement is a good prognostic sign. Loss of consciousness after a 
cerebral infarct implies a poorer prognosis than otherwise. Recovery also depends on the 
size and location of the infarction or hemorrhage. Small infarctions, particularly 
subcortical lacunar strokes, may result in little chronic deficit, whereas large cortical 
infarctions may cause severe, permanent disability. The extent of the infarct governs the 
potential for rehabilitation.  
Patients with massive strokes from which meaningful recovery is unlikely should 
receive palliative care.  Patients who have had a cerebral infarct are at risk for additional 
strokes and for myocardial infarcts. Statin therapy and antiplatelet therapy reduces the 
recurrence rate. Occurrence of stroke in younger patients has a better prognosis than older 
patients. Despite these predictors, the marked variability among patients makes early 
prognostication difficult. 
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AIMS OF THE STUDY 
 
To make a comparative study on clinical profile of stroke in males and females 
with regard to variability in 
 Age Predilection 
 Clinical presentation 
 Type of stroke  
 Frequency of risk factor in each group 
 Outcome difference during the hospital stay 
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MATERIALS AND METHODS 
 
STUDY PLACE:  Dept. Of Medicine, Govt. Stanley Medical College, Chennai. 
STUDY DESIGN:  Prospective Cross Sectional Observational Study.  
STUDY POPULATION:  50 Males and 50 Females. 
INCLUSION CRITERIA: 
All patients admitted with sudden onset of focal neurologic deficit attributable to 
a focal vascular cause.  
EXCLUSION CRITERIA:  
     Patients not satisfying the above said criteria. 
  Patients with an already existing focal neurological deficit. 
  Patients with subdural hemorrhage or extradural hemorrhage. 
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A detailed history is taken and complete physical examination of all the systems 
focusing mainly on neurological and cardiovascular system are performed after taking 
verbal consent from the patient or relatives. All details are recorded on a self designed 
questionnaire which included patient‘s name, age, presenting history, past history of 
cerebro vascular accident or a cardiac disease, hypertension, diabetes mellitus, smoking 
and alcoholism. Findings of the examination are also recorded in the form which includes 
general condition of the patient, peripheral markers of hypercholesterolemia, carotid 
bruit, pulse rate, rhythm, vessel wall thickening, renal bruit, blood pressure, cardiac and 
neurological examination.  
The patients are then subjected to blood investigations like complete blood 
counts, renal function test, blood sugar levels, total cholesterol, ECG, echocardiogram, 
brain imaging like CT. In suspected cases of cortical venous thrombosis, MRI with MR 
venogram was taken. Coagulation profile was done only in suspected cases. 
Type of stroke, site and extent of lesion noted. Patients were treated with all the 
required measures and neurological consultation was sought and their advice was also 
incorporated into the management protocol. These patients were followed up till 
discharge. Daily assessment of the neurological status was done and the prognosis 
assessed. Data analyzed and sorted to see the differences between the two groups. 
Clinical manifestations categorized and risk factors plotted from history as well as from 
the examinations.  
The study conducted is a Prospective Cross Sectional Observational Study on two 
groups of patients. This study has been intended to throw light on the differences in the 
clinical profile of stroke between the representative samples of male and female 
population and thereby to formulate newer prevention strategies. 
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 Table 1     Mean age of stroke presentation in years 
  Number(total) 
Minimum 
age 
Maximum 
age 
Mean 
Male 50 33 83 54.6 
Female 50 25 88 60.1 
Infarct 80 25 88 58.7 
Hemorrhage 20 31 76 52.2 
Mortality Male 12 35 75 52.7 
Mortality 
Female 
6 31 8 60.6 
 
Table 2     Age distribution of stroke in males and females 
Age  
Gender 
Total 
Male Female 
20 – 29 
Total number 0 8 8 
% of Total 0% 16% 8% 
30 – 39 
Total number 10 1 11 
% of Total 20% 2% 11% 
40 – 49 
Total number  10 1 11 
% of Total 20% 2% 11% 
50 – 59 
Total number 8 11 19 
% of Total 16% 22% 19% 
60 – 69 
Total number 11 14 25 
% of Total 22% 28% 25% 
70 – 79 
Total number 10 11 21 
% of Total 20% 22% 21% 
80 and above 
Total number 1 4 5 
% of Total 2% 8% 5% 
Total 
Total number 50 50 100 
% of Total 100% 100% 100% 
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Table 3     Distribution of lesion in males and females 
  Male Female 
Total no. of cases 50 50 
Lesion Infarct Hemorrhage Infarct Hemorrhage 
No. of cases 35 15 45 5 
Percentage 70% 30% 90% 10% 
 
 
 
 
 
 
 
Table 4     Distribution of clinical features in males and females 
 Clinical features Male Female Total 
Altered sensorium 12 24% 12 24% 24 24% 
Headache 9 18% 6 12% 15 15% 
Vomiting 10 20% 4 8% 14 14% 
Seizures 9 18% 7 14% 16 16% 
Aphasia 4 8% 11 22% 15 15% 
Motor deficit 48 96% 49 98% 97 97% 
Sensory deficit 8 16% 3 6% 11 11% 
Facial nerve palsy 26 52% 35 70% 61 61% 
Rest of cranial nerves 
lesions 
10 20% 1 2% 11 11% 
Ataxia 7 14% 1 2% 8 8% 
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Table 6     Distribution of risk factors in males and females 
Risk Factors Male Female Total 
Systemic Hypertension 22 44% 33 66% 55 55% 
Diabetes Mellitus 11 22% 19 38% 30 30% 
Hypercholesterolemia 20 40% 24 48% 44 44% 
Smoking 41 82% 4 8% 45 45% 
Alcoholism 40 80% 1 2% 41 41% 
Coronary Artery Disease 11 22% 6 12% 17 17% 
Atrial Fibrillation 1 2% 5 10% 6 6% 
Left ventricular hypertrophy 3 6% 7 14% 10 10% 
Vascular Malformation 1 2% 0 0% 1 1% 
Carotid Atheroma 3 6% 1 2% 4 4% 
Post Partum 0 0% 4 8% 4 4% 
Hyperhomocysteinemia 3 6% 0 0% 3 3% 
Anti phospholipid antibody syndrome 0 0% 1 2% 1 1% 
Table 5     Lesion wise distribution of clinical features in males and 
females 
                                  Lesion 
 
Clinical Features 
Infarct 
 
Hemorrhage 
 
Male Female Total Male Female Total 
Altered sensorium 9% 18% 14% 60% 80% 65% 
Headache 11% 9% 10% 33% 40% 35% 
Vomiting 14% 7% 10% 33% 20% 30% 
Seizures 11% 13% 13% 33% 20% 30% 
Aphasia 11% 22% 18% 0% 20% 5% 
Motor deficit 97% 98% 98% 100% 100% 100% 
Sensory deficit 17% 7% 11% 13% 0% 10% 
Facial nerve palsy 49% 71% 61% 60% 60% 60% 
Rest of cranial nerves lesions 23% 2% 11% 13% 0% 10% 
Ataxia 20% 2% 10% 0% 0% 0% 
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Table 7     Lesion wise distribution of risk factors in males and 
females 
 
Risk Factors                  Lesion 
   
Infarct Hemorrhage 
Male Female Total Male Female Total 
Systemic Hypertension 40% 67% 55% 53% 60% 55% 
Diabetes Mellitus 23% 38% 31% 20% 40% 25% 
Hypercholesterolemia 51% 51% 51% 13% 20% 15% 
Smoking 91% 9% 45% 60% 0% 45% 
Alcoholism 74% 0% 33% 93% 20% 75% 
Coronary Artery Disease 29% 13% 20% 7% 0% 5% 
Atrial Fibrillation 3% 11% 8% 0% 0% 0% 
Left ventricular hypertrophy 6% 2% 4% 40% 20% 35% 
Vascular Malformation 0% 0% 0% 7% 0% 5% 
Carotid Atheroma 9% 2% 5% 0% 0% 0% 
Post Partum 0% 9% 5% 0% 0% 0% 
Hyperhomocysteinemia 9% 0% 4% 0% 0% 0% 
Anti phospholipid antibody 
syndrome 
0% 2% 1% 0% 0% 0% 
 
Table 8     Distribution of stroke syndromes in males and females 
Syndrome  Male Female Total 
Total anterior circulation  
(TACS) 
Total 
number 
11 14 25 
% of Total 22% 28% 25% 
Partial anterior circulation  
(PACS) 
Total 
number 
5 11 16 
% of Total 10% 22% 16% 
Lacunar  
(LACS) 
 
Total 
number  
26 24 50 
% of Total 52% 48% 50% 
Posterior circulation  
(POCS) 
 
Total 
number 
8 1 9 
% of Total 16% 2% 9% 
Total Total 
number 50 50 100 
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Table 9     Lesion wise distribution of stroke syndrome in males and 
females 
                    Lesion 
 
Syndrome 
 
 Infarct Hemorrhage 
 
Male Female Total Male Female Total 
Total anterior 
circulation  
Total 
number 
3 9 12 8 5 13 
% of 
Total 
9% 20% 15% 53% 100% 65% 
Partial anterior 
circulation  
Total 
number 
4 11 15 1 0 1 
% of 
Total 
11% 24% 19% 7% 0% 5% 
 
Lacunar  
Total 
number  
21 24 45 5 0 5 
% of 
Total 
60% 53% 56% 33% 0% 25% 
 
Posterior circulation  
Total 
number 
7 1 8 1 0 1 
% of 
Total 
20% 2% 10% 7% 0% 5% 
 
Total 
Total 
number 
35 45 80 15 5 20 
% of 
Total 
100% 100% 100% 100% 100% 100% 
  
  Table 10     Outcome in males and females 
Outcome 
 
Male Female Total 
Improved 
Total number 16 20 36 
% of Total 32% 40% 36% 
Static 
Total number 22 21 43 
% of Total 44% 42% 43% 
Mortality 
Total number  12 9 21 
% of Total 24% 18% 21% 
Total 
Total number 50 50 100 
% of Total 100% 100% 100% 
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Table 11     Lesion wise outcome in males and females 
     Lesion 
 
 
Syndrome 
 Infarct Hemorrhage 
Male Female Total Male Female Total 
Improved 
Total 
number 
15 20 35 1 0 1 
% of Total 43% 44% 44% 7% 0% 5% 
Static 
Total 
number 
17 19 36 5 2 7 
% of Total 49% 42% 45% 33% 40% 35% 
Mortality 
Total 
number  
3 6 9 9 3 12 
% of Total 9% 13% 11% 60% 60% 60% 
Total 
Total 
number 
35 45 80 15 5 20 
% of Total 100% 100% 100% 100% 100% 100% 
 
 
 
Table 12     Syndrome wise outcome 
                              Outcome 
Syndrome 
 
Improved Static Mortality 
Total anterior circulation  
Total number 1 8 16 
% of Total 3% 19% 76% 
Partial anterior circulation  
Total number 7 8 1 
% of Total 19% 19% 5% 
 
Lacunar 
Total number 27 21 2 
% of Total 75% 49% 10% 
 
Posterior circulation 
Total number 1 6 2 
% of Total 3% 14% 10% 
 
Total 
Total number 36 43 21 
% of Total 100% 100% 100% 
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Table 13     Syndrome wise outcome in males and females 
            Outcome 
Syndrome 
Improved Static Mortality Total 
 
Total 
No. 
% of 
total 
Total 
No. 
% of 
total 
Total 
No. 
% of 
total 
Total 
No. 
% of 
total 
TACS 0 0% 8 33% 16 67% 24 100% 
 
Male 0 0% 2 18% 9 82% 11 100% 
Female 1 7% 6 43% 7 50% 14 100% 
PACS 7 44% 8 50% 1 6% 16 100% 
 
Male 4 80% 1 20% 0 0% 5 100% 
Female 3 27% 7 64% 1 9% 11 100% 
LACS 27 54% 21 42% 2 4% 50 100% 
 
Male 11 42% 14 54% 1 4% 26 100% 
Female 16 67% 7 29% 1 4% 24 100% 
POCS 1 11% 6 67% 2 22% 9 100% 
 
Male 1 13% 5 63% 2 25% 8 100% 
Female 0 0% 1 100% 0 0% 1 100% 
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Table  14     Risk factors for stroke in young among males and 
females 
Risk factors 
Male  
(Total 10 pts) 
Female  
(Total 9 pts) 
Total (19 pts) 
Total 
No. 
% of 
total 
Total  
No. 
% of 
total 
Total  
No. 
% of 
total 
Systemic Hypertension 
2 20% 1 11% 3 16% 
Diabetes Mellitus 
1 10% 0 0% 1 5% 
Hypercholesterolemia 
0 0% 0 0% 0 0% 
Smoking 
5 50% 0 0% 5 26% 
Alcoholism 
6 60% 0 0% 6 32% 
Coronary artery  
disease 
0 0% 0 0% 0 0% 
Atrial Fibrillation 
1 10% 2 22% 3 16% 
Left ventricular 
hypertrophy 
1 10% 1 11% 2 11% 
Vascular Malformation 
0 0% 0 0% 0 0% 
Carotid Atheroma 
1 10% 0 0% 1 5% 
Post Partum 
0 0% 4 44% 4 21% 
Hyperhomocysteinemia 
3 30% 0 0% 3 16% 
Antiphospholipid 
antibody syndrome 
0 0% 1 11% 1 5% 
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Figure.3- INFARCT RIGHT FRONTAL & PARIETAL LOBE 
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RESULTS 
In the study titled ―Comparative study of stroke in males and females‖, 50 males 
and 50 females were enrolled based on the framed inclusion and exclusion criteria. They 
were analyzed according to their age, clinical features, risk factors, type of stroke and 
outcome. 
In both the sexes, ischemic stroke was the commonest type of stroke accounting 
for 80 % of the total. Out of the 50 males, 15 males had hemorrhagic stroke (30 %) and 
35 males had ischemic stroke (70 %). Among the females studied, 5 females had a 
hemorrhagic stroke (10 %) and 45 females (90 %) had ischemic stroke depicting the 
higher incidence of hemorrhagic stroke in males. Of the hemorrhagic strokes, 87% was 
caused by cerebral bleed and rest 13 % by the subarachnoid hemorrhage. 
The mean age of presentation in males in our study was 54.6 yrs and that of 
females was 60.1yrs. Maximum number of cases in total population was found in the age 
group of 60 – 69 yrs. Mean age for infarct in males and females were 56.3 and 60.5 yrs 
respectively, while that of mean age for hemorrhage in males and females were 50.7 and 
56.4yrs respectively.  
In the two groups, stroke in young had a total of 19 cases, out of which 10 were 
males and 9 were females. Though the difference is not significant, the age group which 
females presented maximally was between 20 – 29 yrs (88%) and that males 
predominated in the 30 – 39 yrs (100%) group. 
 The most common presentation in both the groups was motor deficit accounting 
for 96% in males and 98% in females. Next common presentation was seventh cranial 
nerve palsy accounting for 52% in males and 70% in females. Third common feature was 
altered sensorium in both males and females contributing to 24% each. The presentation  
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of altered sensorium (65%), headache (35%), vomiting (30%) and seizures (30%) were 
more frequent in hemorrhagic stroke than ischemic stroke. 
In both the sexes altered sensorium was the most common presentation of 
hemorrhagic stroke with females outnumbering males (80% against 60%) but the 
frequency of seizures, headache and vomiting were all equal in males (33%) whereas in 
females headache predominated over the other two features (40%). 
Incidence of altered sensorium in ischemic stroke was 18% in females and 9% in 
males. Hence altered sensorium is frequent in females than males irrespective of the 
stroke type, a possible contributing factor for the observed poor outcome in females. 
Ataxia and rest of cranial nerve palsies were observed more frequently in males due to 
the higher incidence of posterior circulation stroke in males. 
 According to the Bamford classification of stroke, the cases were observed and 
analyzed. The most common type of stroke observed was LACS accounting to 52% and 
48% in male and females, followed by TACS 28% in female against 22% in male. The 
third most common stroke in male was POCS 16% while in female the POCS was only 
2%. But PACS was more frequent in a female (22%) than in a male (10%). In cases of 
male infarct the most common type of stroke syndrome was LACS followed by POCS, 
PACS and TACS. Female infarcts also presented commonly with LACS but the second 
common presentation was PACS followed by TACS and POCS. Of the males with 
hemorrhagic stroke the frequently associated stroke syndrome was TACS followed by 
LACS, but all the female hemorrhagic strokes presented with TACS. 
 On analyzing the risk factor profile of the two samples, the most commonly 
associated risk factors in males in the order of association as from the observations made 
was smoking(82%), alcoholism(80%), hypertension (44%), hypercholesterolemia (40%),  
52 
diabetes mellitus and coronary artery disease (CAD) 22% each. In the females, the most 
commonly associated risk factors in the order of occurrence was hypertension (66%), 
hypercholesterolemia (48%), diabetes mellitus (38%), LVH(14%), CAD (12%), and AF 
contributing to 10%.   
 Of the total stroke patients analyzed 55% of patients had hypertension hence 
being the most common risk factor for stroke. Mean arterial blood pressure was higher in 
patients with hemorrhagic strokes (133mmHg in males & 130 in mmHg females) than 
ischemic strokes (115 mmHg in males 117 mmHg in females) and showed no significant 
difference between the groups. In the study 44% of males had hypertension and 66% of 
females had hypertension. Hypertension is the leading risk factor for stroke in females 
but in males the major association is with smoking and alcoholism. Hypertension as a 
risk factor for hemorrhagic stroke was 53% and 60% in the male and the female groups, 
whereas in cases of ischemic stroke females showed a higher association to the extent of 
67% when compared to 40 % in males. 
 Hypercholesterolemia was present in 44% of the population studied, with females 
outnumbering males (48% against 40%). Out of these 93% presented with ischemic 
stroke and the remaining 7% presented with a hemorrhagic stroke. Also of the 80 cases of 
infarct, 51% were hypercholesterolemics and of the 20 cases of hemorrhagic stroke, 15% 
were hypercholesterolemics. Hence hypercholesterolemia is closely associated with 
ischemic stroke rather than hemorrhagic stroke. Hypercholesterolemia contributed as a 
risk factor for stroke in females more than that in males possibly due to postmenopausal 
hormone changes affecting the lipid profile.   
Smoking was observed in 45% of the total patients. Among these 80% had 
ischemic stroke and 20% had hemorrhagic stroke. Smoking was associated with 82% of  
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the male strokes whereas females had an association to about 8%. Only 4 female smokers 
were present in the study and all sustained ischemic stroke. Male smokers present in our 
study were 41 in numbers, out of them 32 (78%) sustained an ischemic stroke and rest 9 
(22%) had a hemorrhagic stroke. Smoking as a risk factor for ischemic stroke in males 
came up to 91% and formed a leading causal factor among male infarcts, whereas it 
accounted for as a risk factor in 9% of female infarcts. Among the hemorrhagic stroke in 
males, smoking was associated as a risk factor in 60%. 
 Alcoholism was observed as the next commonly associated risk factor. Of the 100 
patients, 41 were alcoholic (41%). Among these, 26 sustained ischemic strokes 
accounting to 63% and 15 patients sustained a hemorrhagic stroke accounting to 37%. 
But of the 20 cases of hemorrhagic strokes, alcoholism was associated with 75 % of the 
cases and of the 80 ischemic strokes, 33% were alcoholic. This clearly depicts the closer 
relationship of alcoholism with hemorrhagic stroke more than the ischemic stroke.  
The frequency of male strokes with alcoholism was 80% whereas female strokes 
had a frequency of only 2%. Only one of the female in the study was an alcoholic and she 
presented with a hemorrhagic stroke. In males, 74% of those who had an ischemic stroke 
were alcoholics. The association of alcoholism as a risk factor was stronger for 
hemorrhagic stroke coming up to 93%.  
 Since the habits of alcoholism and smoking were high among our males, they 
contribute as the major risk factor for stroke in this group. This relationship might get 
altered significantly if the female population adapts to these habits. 
 In our study, the next associated risk factor was diabetes mellitus which was 
present in 30 patients (30%). Of these 83% had an ischemic stroke and 17% had a 
hemorrhagic stroke. Of the 80 infarcts, 31% were diabetic and that out of the 20 cases of  
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hemorrhagic strokes, 25% were diabetics. This showed a better correlation of diabetes 
with ischemic stroke than hemorrhagic stroke. Male infarcts had an association with 
diabetes to the extent of 23% whereas females showed an association of 38%. In the 
hemorrhagic strokes also the association of diabetes was 20% in males and 40% in 
females. Thereby in the study conducted, female strokes showed a greater relationship 
with regard to diabetes as a risk factor than males. 
In the study conducted, males were associated with coronary artery disease more 
commonly than females. There was association of coronary artery disease in 22% of 
males and 12% of females.  
Left ventricular hypertrophy was seen in 10% of cases. This also was observed 
more in females than males (14% in females against 6% in males), probably due to the 
higher proportion of hypertensive cases in females compared to males. All of these cases 
sustained ischemic stroke possibly due to the concurrence of other atherosclerotic risk 
factors in these individuals. 
 Atrial fibrillation formed a predominant risk factor among females. In our study, 6 
patients had atrial fibrillation, out of which 5 were females and 1 was a male. Among 
these 6 patients, 5 were rheumatic heart disease and one female was a postpartum 
Cardiomyopathy with left ventricular clot. AF contributed as a risk factor in females to 
the extent of 11% while that in males it was 3%. This disparity is possibly due to the 
higher incidence of rheumatic heart disease in females in our country. 
 In our study, 3 males and 1 female had carotid atheroma. All of these patients 
presented with infarcts. Post partum stroke observed in our study was 4 in number, 3 of 
them presented with venous infarct and one of them presented with post partum 
cardiomyopathy with left ventricular clot. Hyperhomocysteinemia was associated with  
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3 cases of stroke, all were males and presented with infarct as stroke in young. Only one 
case of vascular malformation was observed in the study population. It was a male who 
presented with posterior communicating artery aneurysm with subarachnoid hemorrhage. 
One case of antiphospholipid syndrome was observed. It was a female who presented as 
stroke in young and had deep vein thrombosis of left lower limb at the time of 
presentation. 
 The risk factors with regard to the stroke in young varied considerably between 
the groups. Females predominated with association of post partum CVT and AF whereas 
males predominated with association of alcoholism, smoking, and 
hyperhomocysteinemia.  
On analyzing the outcome in the study, the mean age of mortality in males was 
52.7 yrs and that in females was 60.6 yrs. Males had a poorer outcome than females (case 
fatality rate of 24% in males and that in females was 18%). 
 Among the infarcts, females showed a poorer outcome than males (13% against 
9%) possibly due to the later age of presentation and other potential risk factors that are 
related to age. Among the hemorrhagic strokes, females and males had a similar outcome. 
In total, outcome as observed in our study was poor in males than females, probably due 
to the increased occurrence of hemorrhagic stroke in males.  
The patients who presented with TACS had the worst outcome, of the died 
patients, 76% (57% in males & 43% in females) was contributed by TACS, might be due 
to the fact that it involves a larger area in the brain The best outcome group was the ones 
who presented with LACS (54% improved at the time of their discharge) with females 
predominating males (67% against 42%). On considering the clinical features, those who 
presented with altered sensorium at the time of admission had the worst outcome. Males  
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presenting with altered sensorium had a more chance of dying than females in our study 
(83% in males against 67% in females). Mean arterial blood pressure was high in the 
poor outcome people. Most commonly associated risk factors in the poor outcome group 
varied between male and female. Males predominated with alcoholism while female 
predominated with hypertension. 
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DISCUSSION 
 
In this study conducted, the age, type of stroke, risk factor profile, clinical 
features and outcome of the patient during the hospital study were all observed. These 
findings are herewith described relating to the conclusions of some other similar studies. 
These differences so brought to light will allow us to make conclusions regarding the 
community in which the study is done. 
 We observed that the ischemic strokes (85%) were more common than the 
hemorrhagic stroke (15%). This was the conclusion also cited in American stroke 
association which says 87% of stroke is due to ischemic and 13% is due to hemorrhagic 
stroke. 
In the study it is observed that there was higher incidence of stroke in the older 
age 
31.
The mean age of male strokes was 54.6 yrs and that of female strokes was 60.1 yrs. 
According to study published in American stroke association, the mean age for
 
men were 
68.6 years, and 72.9 years for women, which means that
 
women get their first strokes on 
an average 4.3 years later
 
than men. This was done in the western population. In our 
population it is seen that the mean age is lesser than in the west possibly related to our 
risk factor profile and genetic make
27
. The incidence of stroke in our study in patients 
more than 60 yrs of age in males was 23 in number accounting to 36% and that in 
females was 30 in number accounting to 46 %, depicting a later peaking of stroke 
incidence in females. Studies say stroke is more common among men
 
than women and 
the difference tends to decrease with age with women
 
getting their first stroke about four 
and a half years later than
 
men
67
. 
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In the male population it is seen that the hemorrhagic stroke was common than 
that in the females. In the study done in the west, there is male predomination of 
hemorrhagic stroke
67
. In a study from the WHO MONICA project, the populations from 
Eastern Europe and Finland had higher incidence rates of SAH
 
in men than in women 
similar to our study which showed 2 cases of SAH, all were males. 
The most common presenting feature in both the groups was presence of motor 
deficit (97%). This goes in correlation with our Indian studies conducted, like the one by 
Man Mohan Mehndiratta et al. which found that 80.3% had hemiplegia. Altered 
sensorium and vomiting were all common with the hemorrhagic stroke than ischemic 
stroke. 
 The stroke incidence was observed to be high in the post menopausal women. 
Lesser incidence of women in the reproductive age group is probably related to genetic 
factors, positive effects of estrogen on
 
the cerebral circulation
35
. A lifetime exposure to 
ovarian
 
estrogens may protect against ischemic stroke, at least of the
 
noncardioembolic 
type
16
, an effect that seems to cease with
 
menopause 
40
. 
 Hypertension was the commonest risk factor for both hemorrhagic and ischemic 
stroke. Hypertension is the single most important modifiable risk factor for
 
ischemic 
stroke
69
. Hypertension is the most powerful modifiable risk factor for
 
ICH
36
. Studies 
prove that hypertensive‘s have a fourfold rise of stroke at systolic blood pressure values 
more than 160 mmhg
58
.  
 High blood cholesterol is a major risk factor for heart disease and also increases 
the risk of stroke. Western data‘s suggest that the increased levels of total cholesterol 
especially LDL was associated with higher incidence of ischemic stroke.  
Hypercholesterolemia was found more in females than males in our study. Majority of  
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the cases resulted in ischemic stroke. Studies show that women's total cholesterol is 
higher than men's from age 55 onwards, hence a postmenopausal surge of 
hypercholesterolemics have been noticed in our study. Research suggests that having 
high triglycerides may increase the risk for women more than for men. 
 Diabetes mellitus contributed as a significant risk factor for stroke. According to 
some studies, the frequency of diabetes mellitus was higher in Indian population 18 - 
42% than in the western population 10 - 26%
73
. 
 Cigarette smoking increases risk of ischemic stroke nearly
 
two times
63. 
In our 
study also 80% of the smokers sustained ischemic stroke and rest 20% sustained a 
hemorrhagic stroke. Honolulu heart program links cigarette smoking with both ischemic 
and hemorrhagic stroke. 
Majority of the males in the study were alcoholic and of the hemorrhagic strokes 
it was associated with 75%, supported by studies saying increasing alcohol consumption 
increases
 
risk for brain hemorrhage
24
 . 
 Atrial fibrillation is common in female population than male population in our 
study which has been concluded in many other studies as, women are
 
generally at higher 
risk than men for atrial fibrillation related cardio embolic stroke 
21, 22, 66, 68, 74
. 
 Incidence of CVT as from many studies showed a mean age of 38 years. 
Hypercoagulable state was the most common predisposing factor followed by pregnancy, 
malignancy, and hyperhomocysteinemia. Our study also showed 4 CVT patients, all 
presented as stroke in young, of which 3 were post partum females and one was a 
hyperhomocysteinemic male
33
. 
 In considering the outcome in the two groups, total outcome was poor in the 
males than females possibly due to the higher incidence of hemorrhagic stroke which by  
60 
in itself has a poor outcome. On considering the infarct cases female had a poorer 
outcome than males, possibly due to later age at presentation and associated risk factors 
attributable to age. In a meta analysis, case fatality was higher among women than among 
men in 26 of
 
31 studies, and higher in male patients in only 3 studies. Case fatality was 
1.25 times higher among women
67
. 
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CONCLUSIONS 
 
 Ischemic stroke was the most common type of stroke in both sexes. Hemorrhagic 
stroke was more common in males than females. Of the hemorrhagic strokes, 
intracerebral bleed was more common than subarachnoid hemorrhage. 
 Mean arterial blood pressure was higher in patients with hemorrhagic strokes than 
ischemic strokes and showed no difference between the groups. 
 The mean age of presentation of stroke in males was 54.6 and that in females was 
60.1. Females had later peaking of incidence when compared to males. 
 Among the stroke in young, the case clustering in females was in the third decade, 
whereas in males was in the fourth decade. 
 The most common clinical presentation of stroke was motor deficit followed by 
seventh cranial nerve paralysis and altered sensorium. There was no disparity 
between males and females in this regard. 
 The presentation of altered sensorium, headache, vomiting, and seizures were 
more common in hemorrhagic stroke than ischemic stroke. Among these females 
predominated over males with altered sensorium and headache whereas males 
predominated over females with vomiting and seizures. 
 Ataxia and rest of cranial nerve palsy was more common in males than females. 
The most common type of stroke syndrome in both the sexes were LACS, next    
being TACS. PACS presented more in females and POCS presented more in 
males. 
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 Among the hemorrhagic strokes, the most common clinical syndrome was TACS. 
All the female cases belonged to this type. Even though the commonest clinical 
presentation in males was also TACS, some presented with LACS and PACS. 
 Systemic hypertension is the commonest risk factor attributable to stroke in 
females, whereas smoking formed the predominant risk factor in males. 
 Systemic hypertension was the most commonly associated risk factor for stroke in 
the total population. There was a higher frequency of hypertension in females 
than males. It formed the leading risk factor for stroke in females. 
 Hypercholesterolemia has been associated in females more than that of males 
reflecting the post menopausal effect on the lipid profile. It was predominantly 
associated with ischemic stroke. 
 Smoking was more commonly associated in males than females reflecting the 
altered behavioral pattern in males. Smoking as a risk factor in males is more 
significantly associated with infarcts than hemorrhagic stroke. Smoking therefore 
formed a leading causal factor among male infarcts. 
 Major proportions of the male population in our study were alcoholics. 
Alcoholism as a contribution for causation of stroke was significantly high for 
hemorrhagic stroke than that for infarct. One female alcoholic was present in our 
study, who sustained a hemorrhagic stroke. 
 Diabetes affected more females than males and contributed more towards infarct 
than hemorrhage in both the sexes. 
 Coronary artery disease was more commonly associated with male than females. 
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 Left ventricular hypertrophy is more commonly associated with female than male 
possibly due to the higher incidence of hypertension in females in our study. 
 Atrial fibrillation has been associated more in the females than the males possibly 
due to the higher incidence of rheumatic heart disease in females in our country. 
 Young stroke in females was predominantly observed with the post partum 
females, major proportion due to cortical venous thrombosis. 
 Among the infarcts, mortality rates were higher in females than males possibly 
due to the later age of presentation and other potential risk factors that are related 
to age, but in total, males had a poorer outcome than females probably due to the 
increased occurrence of hemorrhagic stroke in males.  
 Patients who presented with TACS had a poorer outcome and that who presented 
with LACS had good outcome when compared to others. There was no disparity 
between the groups in this respect. 
 Patients who presented with altered sensorium had a poor outcome, with males 
showing greater association than females. 
 The most commonly associated risk factor in the poor outcome group in female 
population was hypertension and that in male population was alcoholism. 
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PROFORMA 
1. Name: 
2. Age: 
3. Sex: 
4. Marital status: 
5. No of Children: 
6. Educational status: 
7. Occupation: 
8. Family Income/yr : 
9. Address: 
10. Clinical presentation on admission: 
11. Time of Onset of symptoms: 
12. H/O Head trauma: 
13. H/O Previous episodes of focal neurological deficit: 
14. Hypertension: Y / N 
        How many yrs: 
        Treatment: 
15. Diabetes: Y / N 
        How many yrs:  
Type: 
        Treatment: 
16. Hyperlipidemia:  Y/N 
       Treatment: 
17. Extramarital / Premarital exposure:  
18. Alcohol: Y /N  
19. Smoking: Y / N 
20. Tobacco chewing: Y / N 
21. Sedentary habits: 
22. Menstrual H/O:  
 Premenopausal / Postmenopausal 
          Menopause:        Yrs since menopause 
23. Diet H /O: Veg /Non Veg 
          Duration 
          Type of cooking oil 
          Salt intake 
          Coffee/Tea 
24. Personality: type A / type B 
25. General examination 
Conscious :                        
Orientation :            
Anemia : 
Clubbing : 
 Icterus :                  
 Pedal edema :              
 JVP : 
 Markers of Hypercholesterolemia : 
 Optic Fundus : 
PR : Rate         /min : Regular/irregular : Vessel wall thickening 
Carotid bruit  + / - 
 BP :                mmHg 
 RR :          / min 
Specific breathing pattern if present –  
26.  CVS:  
       Apical Impulse: 
       Heart Sounds: 
       Murmurs: 
 
  
27.  RS: 
        Air entry: 
        Adventitious sounds: 
28. P /A : 
29.  CNS : 
  Higher functions: 
  Cranial nerves: 
  Motor system: 
Sensory system: 
Cerebellum: 
Extra pyramidal: 
INVESTIGATIONS: 
1.Urine R /E : 
2.RFT : 
   Urea  
            Creatinine 
             Electrolytes                                      
3.CBC:  
     TC                    DC                     ESR 
              Hb                    PCV                   Platelets 
4. FBS 
    PPBS 
5. Total cholesterol: 
6. CXR PA View: 
7. ECG: 
8. CT Brain: 
9. MRI Brain: (if required) 
           
 
CONSENT FORM 
1. I agree to participate in study titled “Comparative study on clinical profile of stroke in 
males and females ― 
 
2. I confirm that I have been told about this study in my mother tongue and have had the 
opportunity to ask questions. 
 
3. I understand that my participation is voluntary and I may refuse to participate at any 
time without giving any reason and without giving any reason and without affecting my 
benefits. 
 
4. I agree not to restrict the use of any data / results that arise from this study. 
 
Name of the participant: 
 
Signature / Thumb print: 
 
Witness:        Investigator: 
  
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 ABBREVIATIONS 
ACA – Anterior Cerebral Artery 
AF – Atrial Fibrillation 
CAD- Coronary Artery Disease 
CSF – Cerebro Spinal fluid 
CT – Computed Tomogram 
CVA – Cerebro Vascular Accident 
CVT – Cerebral Venous Thrombosis 
DALY – Disability Adjusted Life Year 
DM – Diabetes Mellitus 
DVT – Deep Vein Thrombosis 
ECG – Electrocardiogram 
HDL – High Density Lipoprotein 
HT – Hypertension 
ICA – Internal Carotid Artery 
ICH – Intra Cerebral Hemorrhage 
INR – International Normalized Ratio 
IST – International Stroke Trial 
LACS – Lacunar syndrome 
LDL – Low Density Lipoprotein 
LVH – Left Ventricular Hypertrophy 
MCA – Middle Cerebral Artery 
 MRI – Magnetic Resonance Imaging 
NVAF – Non Valvular Atrial Fibrillation 
PACS – Partial Anterior Circulation Syndrome 
PCA – Posterior Cerebral Artery 
PCOM – Posterior Communicating Artery 
PICA – Posterior Inferior Cerebellar Artery 
POCS – Posterior Circulation Syndrome 
RHD – Rheumatic Heart Disease 
rtPA – Recombinant tissue plasminogen activator 
SAH – Sub Arachnoid Hemorrhage 
TACS – Total Anterior Circulation Syndrome 
TC – Total Cholesterol 
TIA – Transient Ischemic Attack 
UTI – Urinary Tract Infection 
VBA – Vertebro Basilar Artery 
WHO – World Health Organization 
 
 
  
 
 
